Literature DB >> 9084804

Identification of a novel HLA-B*2705-restricted cytotoxic T-lymphocyte epitope within a conserved region of HIV-1 Nef.

P J Goulder, A Edwards, R E Phillips, A J McMichael.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9084804

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  5 in total

1.  Intra-host competition between nef-defective escape mutants and wild-type human immunodeficiency virus type 1.

Authors:  H K Altes; V A Jansen
Journal:  Proc Biol Sci       Date:  2000-01-22       Impact factor: 5.349

2.  Favorable and unfavorable HLA class I alleles and haplotypes in Zambians predominantly infected with clade C human immunodeficiency virus type 1.

Authors:  Jianming Tang; Shenghui Tang; Elena Lobashevsky; Angela D Myracle; Ulgen Fideli; Grace Aldrovandi; Susan Allen; Rosemary Musonda; Richard A Kaslow
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

3.  Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses.

Authors:  A D Kelleher; C Long; E C Holmes; R L Allen; J Wilson; C Conlon; C Workman; S Shaunak; K Olson; P Goulder; C Brander; G Ogg; J S Sullivan; W Dyer; I Jones; A J McMichael; S Rowland-Jones; R E Phillips
Journal:  J Exp Med       Date:  2001-02-05       Impact factor: 14.307

4.  Nef-specific CD8+ T cell responses contribute to HIV-1 immune control.

Authors:  Emily Adland; Jonathan M Carlson; Paolo Paioni; Henrik Kløverpris; Roger Shapiro; Anthony Ogwu; Lynn Riddell; Graz Luzzi; Fabian Chen; Thambiah Balachandran; David Heckerman; Anette Stryhn; Anne Edwards; Thumbi Ndung'u; Bruce D Walker; Søren Buus; Philip Goulder; Philippa C Matthews
Journal:  PLoS One       Date:  2013-09-02       Impact factor: 3.240

5.  HLA alleles associated with slow progression to AIDS truly prefer to present HIV-1 p24.

Authors:  José A M Borghans; Anne Mølgaard; Rob J de Boer; Can Keşmir
Journal:  PLoS One       Date:  2007-09-19       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.